Home / Inspections / 1010011

FDA Inspection 1010011 — Innovative Blood Resources, a Division of New York Blood Center, Inc.

Innovative Blood Resources, a Division of New York Blood Center, Inc. — FEI 1970753

The FDA completed an inspection of Innovative Blood Resources, a Division of New York Blood Center, Inc. on May 3, 2017 in Lincoln, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 3, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lincoln, NE (United States)

Facility

Other inspections at this facility

  • 1254117 (NAI Wed Oct 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1094235 (NAI Fri May 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 924205 (VAI Fri Apr 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 791984 (VAI Mon Jul 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 743696 (VAI Fri Sep 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources